A morphological characterization of the Habbanite community in Israel included about 25 anthropometric measurements and some 10 observations for 239 males and 267 females. The Habbanites can be described as rather short in stature, hyperbrachycephalic with long but narrow facial features. Heights and weights estimates of 275 Habbanite boys and girls, 6–17 years of age, are much lower than those of British or US children (below the 3rd percentile), and also lower than those of children from various other ethnic groups in Israel. The coefficient of variations for metric characteristics is not different between the sexes. Uniformity of type is also reflected in traits such as hair and eye color. Determination of taste thresholds for phenylthiocarbamide (PTC) indicates solutions No. 9 and 10 as the mode for tasters. The percentage of non-tasters is not very low (19.75%). Only two males had defects in color vision; both their mothers were not from Habban. The Habbanites’ physical features do not resemble those of the populations surrounding them or among whom they have been dwelling for several hundred years. It is claimed that on the basis of these results, together with the serological and dermatoglyphic data, the Habbanites can be regarded as a true genetic isolate.

Keywords:
Habbanite isolate, Population study, Anthropological traits, Color vision, PTC taste ability
This content is only available via PDF.
© 1972 S. Karger AG, Basel
1972
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.